BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Masola V, Greco N, Gambaro G, Franchi M, Onisto M. Heparanase as active player in endothelial glycocalyx remodeling. Matrix Biol Plus 2022;13:100097. [PMID: 35036899 DOI: 10.1016/j.mbplus.2021.100097] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Fels B, Acharya S, Vahldieck C, Graf T, Käding N, Rupp J, Kusche-Vihrog K. Mineralocorticoid receptor-antagonism prevents COVID-19-dependent glycocalyx damage. Pflugers Arch 2022. [PMID: 35867189 DOI: 10.1007/s00424-022-02726-3] [Reference Citation Analysis]
2 Szeremeta A, Jura-półtorak A, Zoń-giebel A, Olczyk K, Komosińska-vassev K. TNF-α Inhibitors in Combination with MTX Reduce Circulating Levels of Heparan Sulfate/Heparin and Endothelial Dysfunction Biomarkers (sVCAM-1, MCP-1, MMP-9 and ADMA) in Women with Rheumatoid Arthritis. JCM 2022;11:4213. [DOI: 10.3390/jcm11144213] [Reference Citation Analysis]
3 Drost CC, Rovas A, Osiaevi I, Rauen M, van der Vlag J, Buijsers B, Salmenov R, Lukasz A, Pavenstädt H, Linke WA, Kümpers P. Heparanase Is a Putative Mediator of Endothelial Glycocalyx Damage in COVID-19 - A Proof-of-Concept Study. Front Immunol 2022;13:916512. [PMID: 35757776 DOI: 10.3389/fimmu.2022.916512] [Cited by in F6Publishing: 1] [Reference Citation Analysis]